<p>在過去的 7 天裏，市場下跌了 1.9%，儘管過去一年上漲了 15%，預計收益將以每年 15% 的速度增長。雖然便士股票可能看起來像是過去交易日的迴響，但當與財務狀況良好的公司相關聯時，它們仍然提供了相關的增長機會。本文探討了三隻在當今市場環境中因其潛力和財務穩健性而脱穎而出的便士股票。</p>
<h3>美國十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>ATRenew (RERE)</td>
<td>$4.81</td>
<td>$10.7 億</td>
<td>✅ 4 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$2.07</td>
<td>$3.4831 億</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Tuya (TUYA)</td>
<td>$2.33</td>
<td>$14.1 億</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>FinVolution Group (FINV)</td>
<td>$4.66</td>
<td>$11.8 億</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Tuniu (TOUR)</td>
<td>$0.7698</td>
<td>$8932 萬</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Information Services Group (III)</td>
<td>$3.11</td>
<td>$1.7926 億</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Golden Growers Cooperative (GGRO.U)</td>
<td>$5.00</td>
<td>$7745 萬</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Niagen Bioscience (NAGE)</td>
<td>$4.20</td>
<td>$3.3704 億</td>
<td>✅ 3 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Cricut (CRCT)</td>
<td>$3.79</td>
<td>$8.0265 億</td>
<td>✅ 2 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>LifeVantage (LFVN)</td>
<td>$4.30</td>
<td>$5506 萬</td>
<td>✅ 4 ⚠️ 3 查看分析 </td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們美國便士股票篩選器中的 368 只股票的完整列表。</p>
<p>讓我們探索篩選器結果中的幾個突出選項。</p>
<h2>Arq (ARQ)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Arq, Inc.是一家環境技術公司，提供可消耗的空氣、水和土壤處理解決方案，使用活性炭在美國和加拿大運營，市值為 1.0884 億美元。</p>
<p><strong>運營：</strong> 公司的收入主要來自其先進淨化技術部門，金額為 1.2034 億美元。</p>
<p><strong>市值：</strong> 1.0884 億美元</p>
<p>Arq, Inc.市值為 1.0884 億美元，正在應對重大運營挑戰和財務調整。最近的財報顯示，2025 年淨虧損達到 5261 萬美元，主要由於減值和因熱氧化器工程問題而暫停生產。暫停 GAC 生產的決定影響了 2026 年的收入預期，預計為 1.2 億至 1.25 億美元。儘管面臨這些困難，Arq 的債務水平仍然令人滿意，淨債務與股本比率為 12.8%。領導層的變動旨在解決運營效率低下的問題，因為公司專注於優化其單一工廠的運營，尤其是在 Corbin 設施閒置之後。</p>
<ul>
<li>解鎖我們對 Arq 股票分析的全面見解，查看此財務健康報告。</li>
<li>在我們的增長報告中探索 Arq 的分析師預測。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fe91fa12-b6de-4461-b84d-ab41631171f9/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fe91fa12-b6de-4461-b84d-ab41631171f9/chart/financial-position-analysis"/></p>
<p>ARQ 財務狀況分析截至 2026 年 3 月</p>
<h2>Sight Sciences (SGHT)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Sight Sciences, Inc.是一家眼科醫療設備公司，開發和商業化用於治療美國常見眼病的外科和非外科技術，市值為 2.0954 億美元。</p>
<p><strong>運營：</strong> Sight Sciences 的收入來自兩個主要部門：外科青光眼，貢獻 7572 萬美元，乾眼，收入為 164 萬美元。</p>
<p><strong>市值：</strong> 2.0954 億美元</p>
<p>Sight Sciences, Inc.市值為 2.0954 億美元，正在經歷財務挑戰，但在其核心部門顯示出潛在增長。公司報告 2025 年淨虧損 3843 萬美元，儘管過去五年的虧損年均下降 3.5%。2025 年外科青光眼部門的收入為 7572 萬美元，乾眼部門的收入為 164 萬美元，2026 年的整體收入預計將增長至 8200 萬至 8800 萬美元。儘管處於虧損狀態且股價波動較大，但由於強大的資產管理，其現金流超過三年。</p>
<ul>
<li>通過我們的綜合資產負債表健康報告，深入瞭解 Sight Sciences 的複雜性。</li>
<li>通過訪問我們的收益增長報告，評估 Sight Sciences 的前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/24162356-af72-4029-8687-2ca3e6aa6a2f/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/24162356-af72-4029-8687-2ca3e6aa6a2f/chart/financial-position-analysis"/></p>
<p>SGHT 財務狀況分析截至 2026 年 3 月</p>
<h2>Chegg (CHGG)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Chegg, Inc.運營一個學習平台，支持全球企業、終身學習者和學生的技能發展，市值約為 7654 萬美元。</p>
<p><strong>運營：</strong> 公司的收入來自其教育服務部門，特別是在教育與培訓服務方面，金額為 3.7691 億美元。</p>
<p><strong>市值：</strong> 7654 萬美元</p>
<p>Chegg, Inc.市值為 7654 萬美元，正在應對財務障礙，同時專注於通過其 Chegg Skills 平台實現戰略增長。公司報告 2025 年銷售額顯著下降至 3.7691 億美元，淨虧損從前一年縮小，但仍然高達 1.0342 億美元。儘管處於虧損狀態且股價波動較大，Chegg 的現金儲備超過其總債務，並舒適地覆蓋長期負債。與 Woolf 的新合作伙伴關係旨在增強全球技能教育產品，儘管當前盈利預測面臨挑戰，但可能會增強未來的收入來源。</p>
<ul>
<li>點擊這裏發現 Chegg 的細微差別，查看我們的詳細分析財務健康報告。</li>
<li>通過檢查我們的增長報告，瞭解 Chegg 的收益前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/441eb5c1-294a-405f-9458-103e2cbc98cf/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/441eb5c1-294a-405f-9458-103e2cbc98cf/chart/financial-position-analysis"/></p>
<p>CHGG 財務狀況分析截至 2026 年 3 月</p>
<h2>將想法轉化為行動</h2>
<ul>
<li>點擊這裏，揭示我們美國便士股票篩選器中的 368 個隱藏寶石。</li>
<li>想探索一些替代方案嗎？特朗普的石油繁榮來了——管道準備好獲利。發現 22 只乘風而起的美國股票。</li>
</ul>
<p><em>這篇文章來自 Simply Wall St，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
<h3><strong>新功能：</strong> 在一個地方管理您的所有股票投資組合</h3>
<p>我們為股票投資者創建了 <strong>終極投資組合助手</strong>，<strong>而且是免費的。</strong></p>
<p>• 連接無限數量的投資組合，並以一種貨幣查看您的總額</p>
<p>• 通過電子郵件或手機接收新的警告信號或風險提示</p>
<p>• 跟蹤您股票的公允價值</p>
<p>免費試用演示投資組合</p>

SGHT

ETEC

環境服務 ETF - VanEck Vectors

標普健康醫療設備 ETF - SPDR

美國醫藥設備 ETF - iShares

CHGG

<p>這篇文章討論了三隻有前景的便士股票：Arq、Sight Sciences 和 Chegg。在過去一週市場下跌了 1.9%，但在過去一年中上漲了 15%。Arq 是一家環保科技公司，面臨運營挑戰，預計 2026 年的收入為 1.2 億至 1.25 億美元，而 2025 年淨虧損為 5261 萬美元。Sight Sciences 是一家眼科設備公司，報告了 3843 萬美元的淨虧損，但預計 2026 年的收入將增長至 8200 萬至 8800 萬美元。Chegg 是一家教育平台，正在應對財務困難，銷售大幅下降，但旨在通過新的合作伙伴關係提升產品服務</p>

<p>Over the last 7 days, the market has dropped 1.9%, although it is up 15% over the past year, with earnings forecast to grow by 15% annually. While penny stocks might seem like a nod to bygone trading days, they still offer relevant opportunities for growth when tied to companies with strong financials. This article explores three such penny stocks that stand out for their potential and financial robustness in today's market landscape.</p>
<div class="lb-trans"><p>在過去的 7 天裏，市場下跌了 1.9%，儘管過去一年上漲了 15%，預計收益將以每年 15% 的速度增長。雖然便士股票可能看起來像是過去交易日的迴響，但當與財務狀況良好的公司相關聯時，它們仍然提供了相關的增長機會。本文探討了三隻在當今市場環境中因其潛力和財務穩健性而脱穎而出的便士股票。</p>
</div><h3>Top 10 Penny Stocks In The United States</h3>
<div class="lb-trans"><h3>美國十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>ATRenew (RERE)</td>
<td>$4.81</td>
<td>$1.07B</td>
<td>✅ 4 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$2.07</td>
<td>$348.31M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Tuya (TUYA)</td>
<td>$2.33</td>
<td>$1.41B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>FinVolution Group (FINV)</td>
<td>$4.66</td>
<td>$1.18B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Tuniu (TOUR)</td>
<td>$0.7698</td>
<td>$89.32M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Information Services Group (III)</td>
<td>$3.11</td>
<td>$179.26M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Golden Growers Cooperative (GGRO.U)</td>
<td>$5.00</td>
<td>$77.45M</td>
<td>✅ 2 ⚠️ 5 View Analysis &gt;</td>
</tr>
<tr>
<td>Niagen Bioscience (NAGE)</td>
<td>$4.20</td>
<td>$337.04M</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Cricut (CRCT)</td>
<td>$3.79</td>
<td>$802.65M</td>
<td>✅ 2 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>LifeVantage (LFVN)</td>
<td>$4.30</td>
<td>$55.06M</td>
<td>✅ 4 ⚠️ 3 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>ATRenew (RERE)</td>
<td>$4.81</td>
<td>$10.7 億</td>
<td>✅ 4 ⚠️ 0 查看分析 </td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$2.07</td>
<td>$3.4831 億</td>
<td>✅ 3 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Tuya (TUYA)</td>
<td>$2.33</td>
<td>$14.1 億</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>FinVolution Group (FINV)</td>
<td>$4.66</td>
<td>$11.8 億</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Tuniu (TOUR)</td>
<td>$0.7698</td>
<td>$8932 萬</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Information Services Group (III)</td>
<td>$3.11</td>
<td>$1.7926 億</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Golden Growers Cooperative (GGRO.U)</td>
<td>$5.00</td>
<td>$7745 萬</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Niagen Bioscience (NAGE)</td>
<td>$4.20</td>
<td>$3.3704 億</td>
<td>✅ 3 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Cricut (CRCT)</td>
<td>$3.79</td>
<td>$8.0265 億</td>
<td>✅ 2 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>LifeVantage (LFVN)</td>
<td>$4.30</td>
<td>$5506 萬</td>
<td>✅ 4 ⚠️ 3 查看分析 </td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 368 stocks from our US Penny Stocks screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們美國便士股票篩選器中的 368 只股票的完整列表。</p>
</div><p>Let's explore several standout options from the results in the screener.</p>
<div class="lb-trans"><p>讓我們探索篩選器結果中的幾個突出選項。</p>
</div><h2>Arq (ARQ)</h2>
<div class="lb-trans"><h2>Arq (ARQ)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Arq, Inc. is an environmental technology company that provides consumable air, water, and soil treatment solutions using activated carbon in the United States and Canada, with a market cap of $108.84 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Arq, Inc.是一家環境技術公司，提供可消耗的空氣、水和土壤處理解決方案，使用活性炭在美國和加拿大運營，市值為 1.0884 億美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily generated from its Advanced Purification Technologies segment, amounting to $120.34 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入主要來自其先進淨化技術部門，金額為 1.2034 億美元。</p>
</div><p><strong>Market Cap:</strong> $108.84M</p>
<div class="lb-trans"><p><strong>市值：</strong> 1.0884 億美元</p>
</div><p>Arq, Inc., with a market cap of US$108.84 million, is navigating significant operational challenges and financial adjustments. Recent earnings reports highlighted a substantial net loss of US$52.61 million for 2025, driven by impairments and halted production due to engineering issues with its thermal oxidizer. The decision to pause GAC production impacts revenue expectations for 2026, projected at US$120-125 million. Despite these hurdles, Arq maintains satisfactory debt levels with a net debt to equity ratio of 12.8%. Leadership changes aim to address operational inefficiencies as the company focuses on optimizing its single-plant operations post-Corbin facility idling.</p>
<div class="lb-trans"><p>Arq, Inc.市值為 1.0884 億美元，正在應對重大運營挑戰和財務調整。最近的財報顯示，2025 年淨虧損達到 5261 萬美元，主要由於減值和因熱氧化器工程問題而暫停生產。暫停 GAC 生產的決定影響了 2026 年的收入預期，預計為 1.2 億至 1.25 億美元。儘管面臨這些困難，Arq 的債務水平仍然令人滿意，淨債務與股本比率為 12.8%。領導層的變動旨在解決運營效率低下的問題，因為公司專注於優化其單一工廠的運營，尤其是在 Corbin 設施閒置之後。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Arq stock in this financial health report.</li>
<li>Explore Arq's analyst forecasts in our growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖我們對 Arq 股票分析的全面見解，查看此財務健康報告。</li>
<li>在我們的增長報告中探索 Arq 的分析師預測。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fe91fa12-b6de-4461-b84d-ab41631171f9/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/fe91fa12-b6de-4461-b84d-ab41631171f9/chart/financial-position-analysis"/></p>
<p>ARQ Financial Position Analysis as at Mar 2026</p>
<div class="lb-trans"><p>ARQ 財務狀況分析截至 2026 年 3 月</p>
</div><h2>Sight Sciences (SGHT)</h2>
<div class="lb-trans"><h2>Sight Sciences (SGHT)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Sight Sciences, Inc. is an ophthalmic medical device company that develops and commercializes surgical and nonsurgical technologies for treating prevalent eye diseases in the United States, with a market cap of $209.54 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Sight Sciences, Inc.是一家眼科醫療設備公司，開發和商業化用於治療美國常見眼病的外科和非外科技術，市值為 2.0954 億美元。</p>
</div><p><strong>Operations:</strong> Sight Sciences generates revenue from two primary segments: Surgical Glaucoma, which contributes $75.72 million, and Dry Eye, accounting for $1.64 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> Sight Sciences 的收入來自兩個主要部門：外科青光眼，貢獻 7572 萬美元，乾眼，收入為 164 萬美元。</p>
</div><p><strong>Market Cap:</strong> $209.54M</p>
<div class="lb-trans"><p><strong>市值：</strong> 2.0954 億美元</p>
</div><p>Sight Sciences, Inc., with a market cap of US$209.54 million, is experiencing financial challenges yet shows potential growth in its core segments. The company reported a net loss of US$38.43 million for 2025, although losses have decreased over the past five years at an annual rate of 3.5%. Revenue from the Surgical Glaucoma segment was US$75.72 million and Dry Eye segment revenue was US$1.64 million in 2025, with projections for 2026 suggesting growth to between US$82-88 million overall. Despite being unprofitable and having high share price volatility, its cash runway exceeds three years due to strong asset management.</p>
<div class="lb-trans"><p>Sight Sciences, Inc.市值為 2.0954 億美元，正在經歷財務挑戰，但在其核心部門顯示出潛在增長。公司報告 2025 年淨虧損 3843 萬美元，儘管過去五年的虧損年均下降 3.5%。2025 年外科青光眼部門的收入為 7572 萬美元，乾眼部門的收入為 164 萬美元，2026 年的整體收入預計將增長至 8200 萬至 8800 萬美元。儘管處於虧損狀態且股價波動較大，但由於強大的資產管理，其現金流超過三年。</p>
</div><ul>
<li>Navigate through the intricacies of Sight Sciences with our comprehensive balance sheet health report here.</li>
<li>Evaluate Sight Sciences' prospects by accessing our earnings growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>通過我們的綜合資產負債表健康報告，深入瞭解 Sight Sciences 的複雜性。</li>
<li>通過訪問我們的收益增長報告，評估 Sight Sciences 的前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/24162356-af72-4029-8687-2ca3e6aa6a2f/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/24162356-af72-4029-8687-2ca3e6aa6a2f/chart/financial-position-analysis"/></p>
<p>SGHT Financial Position Analysis as at Mar 2026</p>
<div class="lb-trans"><p>SGHT 財務狀況分析截至 2026 年 3 月</p>
</div><h2>Chegg (CHGG)</h2>
<div class="lb-trans"><h2>Chegg (CHGG)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Chegg, Inc. operates a learning platform that supports skill development for businesses, lifelong learners, and students globally, with a market cap of approximately $76.54 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Chegg, Inc.運營一個學習平台，支持全球企業、終身學習者和學生的技能發展，市值約為 7654 萬美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is generated from its Educational Services segment, specifically in Education &amp; Training Services, amounting to $376.91 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入來自其教育服務部門，特別是在教育與培訓服務方面，金額為 3.7691 億美元。</p>
</div><p><strong>Market Cap:</strong> $76.54M</p>
<div class="lb-trans"><p><strong>市值：</strong> 7654 萬美元</p>
</div><p>Chegg, Inc., with a market cap of US$76.54 million, is navigating financial hurdles while focusing on strategic growth through its Chegg Skills platform. The company reported a significant decline in sales to US$376.91 million for 2025, with net losses narrowing from the previous year but remaining substantial at US$103.42 million. Despite being unprofitable and experiencing high share price volatility, Chegg's cash reserves surpass its total debt and cover long-term liabilities comfortably. A new partnership with Woolf aims to enhance skill-based education offerings globally, potentially bolstering future revenue streams despite current challenges in profitability forecasts over the next three years.</p>
<div class="lb-trans"><p>Chegg, Inc.市值為 7654 萬美元，正在應對財務障礙，同時專注於通過其 Chegg Skills 平台實現戰略增長。公司報告 2025 年銷售額顯著下降至 3.7691 億美元，淨虧損從前一年縮小，但仍然高達 1.0342 億美元。儘管處於虧損狀態且股價波動較大，Chegg 的現金儲備超過其總債務，並舒適地覆蓋長期負債。與 Woolf 的新合作伙伴關係旨在增強全球技能教育產品，儘管當前盈利預測面臨挑戰，但可能會增強未來的收入來源。</p>
</div><ul>
<li>Click here to discover the nuances of Chegg with our detailed analytical financial health report.</li>
<li>Understand Chegg's earnings outlook by examining our growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏發現 Chegg 的細微差別，查看我們的詳細分析財務健康報告。</li>
<li>通過檢查我們的增長報告，瞭解 Chegg 的收益前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/441eb5c1-294a-405f-9458-103e2cbc98cf/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/441eb5c1-294a-405f-9458-103e2cbc98cf/chart/financial-position-analysis"/></p>
<p>CHGG Financial Position Analysis as at Mar 2026</p>
<div class="lb-trans"><p>CHGG 財務狀況分析截至 2026 年 3 月</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>將想法轉化為行動</h2>
</div><ul>
<li>Reveal the 368 hidden gems among our US Penny Stocks screener with a single click here.</li>
<li>Want To Explore Some Alternatives? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏，揭示我們美國便士股票篩選器中的 368 個隱藏寶石。</li>
<li>想探索一些替代方案嗎？特朗普的石油繁榮來了——管道準備好獲利。發現 22 只乘風而起的美國股票。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇文章來自 Simply Wall St，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div><h3><strong>New:</strong> Manage All Your Stock Portfolios in One Place</h3>
<div class="lb-trans"><h3><strong>新功能：</strong> 在一個地方管理您的所有股票投資組合</h3>
</div><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p>
<div class="lb-trans"><p>我們為股票投資者創建了 <strong>終極投資組合助手</strong>，<strong>而且是免費的。</strong></p>
</div><p>• Connect an unlimited number of Portfolios and see your total in one currency</p>
<div class="lb-trans"><p>• 連接無限數量的投資組合，並以一種貨幣查看您的總額</p>
</div><p>• Be alerted to new Warning Signs or Risks via email or mobile</p>
<div class="lb-trans"><p>• 通過電子郵件或手機接收新的警告信號或風險提示</p>
</div><p>• Track the Fair Value of your stocks</p>
<div class="lb-trans"><p>• 跟蹤您股票的公允價值</p>
</div><p>Try a Demo Portfolio for Free</p>
<div class="lb-trans"><p>免費試用演示投資組合</p>
</div>

Arq 及其他兩個有潛力的便士股票